Compare FAST & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FAST | EW |
|---|---|---|
| Founded | 1967 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4B | 45.5B |
| IPO Year | N/A | 2000 |
| Metric | FAST | EW |
|---|---|---|
| Price | $41.68 | $85.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 20 |
| Target Price | $44.61 | ★ $92.78 |
| AVG Volume (30 Days) | ★ 6.6M | 3.4M |
| Earning Date | 01-16-2026 | 10-30-2025 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ 6.38 | N/A |
| EPS | 1.07 | ★ 2.33 |
| Revenue | ★ $7,997,600,000.00 | $5,883,800,000.00 |
| Revenue This Year | $10.88 | $14.26 |
| Revenue Next Year | $8.98 | $9.77 |
| P/E Ratio | $39.06 | ★ $36.82 |
| Revenue Growth | 6.92 | ★ 10.60 |
| 52 Week Low | $35.31 | $65.94 |
| 52 Week High | $50.63 | $87.40 |
| Indicator | FAST | EW |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 57.55 |
| Support Level | $39.81 | $83.60 |
| Resistance Level | $40.70 | $87.40 |
| Average True Range (ATR) | 0.74 | 1.76 |
| MACD | 0.35 | -0.35 |
| Stochastic Oscillator | 88.75 | 58.58 |
Fastenal began as an industrial retailer, expanding its product portfolio from nuts and bolts to cutting tools, safety equipment, and janitorial supplies. It transitioned into a distributor by building out a dense network of branches close to its business customers. Once a customer becomes large enough, Fastenal installs vending machines and its own personnel on-site. Today, these on-site locations exceed Fastenal's branch count and remain the firm's main focus for expansion. Fastenal acts as a one-stop outsourcing partner for its industrial customers, offering value-added services along with a wide breadth of maintenance, repair, and operations supplies.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.